CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Haemato AG Company Snapshot
Haemato AG operates in the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Haemato AG with three other drug stores in Europe: Medika d.d. of Croatia (2015 sales of 2.50 billion Croatian Kuna [US$361.87 million] ), Salus Ljubljana DD of Slovenia (199.95 million Euro [US$214.77 million] ), and Sopharma Trading AD which is based in Bulgaria (608.81 million Bulgarian Lev [US$334.33 million] ).

Sales Analysis. Haemato AG reported sales of 229.73 million Euro (US$246.75 million) for the year ending December of 2015. This represents an increase of 13.3% versus 2014, when the company's sales were 202.67 million Euro. This was the fourth straight year of sales growth at Haemato AG.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Haemato AG
  Stock Performance Chart for Haemato AG
 
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 6.49
(Figures in Euro)
1 Week 1.5%   13 Weeks -2.2%  
4 Weeks 3.4%   52 Weeks 34.9%  
 
Haemato AG Key Data:
  Ticker: HAE Country: Germany
  Exchanges: FRA Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2015 Sales 229,727,262
(Year Ending Jan 2016).
Employees: 173
  Currency: Euro Market Cap: 134,938,164
  Fiscal Yr Ends: December Shares Outstanding: 20,778,898
  Share Type: Inhaberstammaktien Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.